Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

All-Cause and Cause-Specific Mortality by SEER Stage in Gastric Cancer: A Nationwide Population-Based Cohort Study.

Journal of clinical medicine·2026
Same author

Associations of nutritional intake and body mass index with branch retinal vein occlusion: A cross-sectional study using data from a Korean national survey.

Science progress·2026
Same author

Defining Korean Epidemiologic Cutoffs for <i>Helicobacter pylori</i>: from Minimum Inhibitory Concentration Distributions to Clinical Implications.

Gut and liver·2026
Same author

Hormone replacement therapy and the risk of achalasia in postmenopausal women: A nationwide cohort study.

Medicine·2026
Same author

Increased Heart Failure Risk with Gastric Cancer Progression: A Nationwide Population-Based Cohort Study.

Gut and liver·2025
Same author

Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality.

The Korean journal of helicobacter and upper gastrointestinal research·2025

関連する実験動画

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

薬物開発

Jin Kyung Lee1, Juho Lee1, Jaemin Shin1

  • 1ILLIMIS THERAPEUTICS, Seoul, Gangnam-gu, Korea, Republic of (South).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ

GAIA-Aβは、食作用のためのTAM受容体を活用することにより、アミロイドβ（Aβ）を効果的に除去し、神経炎症を軽減します。この新しいアプローチは、現在の抗体治療と比較して、アルツハイマー病のより安全な治療法として有望視されています。

キーワード:
アルツハイマー病アミロイドβ神経炎症食作用TAM受容体薬物開発GAIA-Aβ治療法

さらに関連する動画

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

関連する実験動画

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学分野:

  • 神経科学
  • 免疫学
  • 薬理学

背景:

  • アミロイドβ（Aβ）の蓄積はアルツハイマー病（AD）の中心です。
  • 現在の抗Aβ抗体療法はAβ負荷を軽減しますが、神経炎症やARIAを引き起こす可能性があります。
  • GAIAプラットフォームは、TAM受容体を利用して食作用を介したAβクリアランスを行い、炎症性副作用を回避することを目的としています。

研究 の 目的:

  • GAIA-Aβの薬物動態学的特性を評価すること。
  • Aβ負荷と神経炎症を軽減するためのGAIA-Aβの治療効果を評価すること。
  • 既存の抗Aβ免疫療法と比較してGAIA-Aβの安全性プロファイルを評価すること。

主な方法:

  • GAIA-Aβは、GAS6およびAβ標的化ドメインで設計されました。
  • ELISAにより、オリゴマーAβ（oAβ）およびTAM受容体への結合親和性を確認しました。
  • 食作用、抗炎症応答、薬物動態、および5xFADマウスにおけるinvivo有効性を評価しました。

主要な成果:

  • GAIA-Aβは、oAβおよびTAM受容体への特異的結合を示しました。
  • 食作用アッセイでは、炎症性サイトカインの減少を伴う効果的なoAβクリアランスが示されました。
  • 5xFADマウスを用いたinvivo研究では、Aβプラークの有意な減少とグリア細胞によるクリアランスの向上が明らかになりました。

結論:

  • GAIA-Aβは、Aβ負荷を効果的に軽減し、神経炎症を緩和します。
  • この治療法は、現在の抗Aβ抗体と比較して、潜在的に有利な安全性プロファイルを示します。
  • GAIA-Aβは、アルツハイマー病の有望な治療戦略を提供します。